Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

NECA and patient advocates take MTC treatment access to Parliament

March4NETs in the Media – 2026

NECA attends Australian Patient Advocacy Alliance Summit at Parliament House

NECA CEO Meredith Cummins is Now INCA President

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.